ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.034,51
0,23%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,0767
0,09%
Bitcoin
64.500,54
0,78%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Disc Medicine Inc (IRON)

  7. Disc Medicine Inc (IRON) News

IRON

Disc Medicine (IRON)

Disc Medicine Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IRON
DatumZeitQuelleÜberschriftSymbolFirma
01/04/202414h00GlobeNewswire Inc.Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
21/03/202413h00GlobeNewswire Inc.Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
06/03/202422h30GlobeNewswire Inc.Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024NASDAQ:IRONDisc Medicine Inc
02/03/202401h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202401h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202401h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
26/02/202414h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
26/02/202414h30GlobeNewswire Inc.Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial OfficerNASDAQ:IRONDisc Medicine Inc
20/02/202414h30GlobeNewswire Inc.Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseNASDAQ:IRONDisc Medicine Inc
15/02/202422h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
14/02/202400h51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRONDisc Medicine Inc
09/02/202415h00GlobeNewswire Inc.Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia VeraNASDAQ:IRONDisc Medicine Inc
07/02/202414h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
07/02/202414h00GlobeNewswire Inc.Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating OfficerNASDAQ:IRONDisc Medicine Inc
06/02/202422h55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
23/01/202423h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
04/01/202422h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
03/01/202423h00GlobeNewswire Inc.Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRONDisc Medicine Inc
03/01/202422h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
02/01/202422h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
29/12/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
20/12/202322h30GlobeNewswire Inc.Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory BoardNASDAQ:IRONDisc Medicine Inc
14/12/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
12/12/202322h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
12/12/202302h30GlobeNewswire Inc.Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
11/12/202318h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
11/12/202318h00GlobeNewswire Inc.Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
07/12/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
07/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRONDisc Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:IRON

Kürzlich von Ihnen besucht

PM
XAUUSD
Gold vs US Dollar
TG
BAS
BASF
USOTC
RHHBY
Roche (QX)
TG
CBK
Commerzbank
DBI
TDXP
Tec DAX
NASDAQ
MSFT
Microsoft
DBI
DAX
DAX
NASDAQ
AAPL
Apple
TG
BAYN
Bayer
NASDAQ
NVDA
NVIDIA
TG
NOV
Novo Nordisk
TG
DBK
Deutsche Bank
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten